NCT00881816View on ClinicalTrials.gov

Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2009

Conditions
Advanced Gastric Carcinoma
Interventions
DRUG

Liposomal paclitaxel plus capecitabine

All Patients will receive liposomal paclitaxel (with a dose of 60mg/m2,3h,ivgtt,at d1,8,15) and capecitabine (with a dose of 1600mg/m2,bid,po.,at d1-14),each cycle for 4 cycles.

Sponsors
All Listed Sponsors
lead

Nanjing Sike Pharmaceutical Co., Ltd.

INDUSTRY